Safety, pharmacokinetics, and preliminary efficacy of a specific anti-IL-1alpha 
therapeutic antibody (MABp1) in patients with type 2 diabetes mellitus

Timper, Katharina; Seelig, Eleonora; Tsakiris, Dimitrios A.; Donath, Marc Y.

doi:10.1016/j.jdiacomp.2015.05.019

Local TagsRelease HistoryDetailsSummary

Safety, pharmacokinetics, and preliminary efficacy of a specific anti-IL-1alpha therapeutic antibody (MABp1) in patients with type 2 diabetes mellitus

Timper, K., Seelig, E., Tsakiris, D. A., & Donath, M. Y. (2015). Safety, pharmacokinetics, and preliminary efficacy of a specific anti-IL-1alpha therapeutic antibody (MABp1) in patients with type 2 diabetes mellitus. Journal of Diabetes and Its Complications, 29(7), 955-960. doi:10.1016/j.jdiacomp.2015.05.019.

Item is Released

show all hide all

Basic

show hide

Item Permalink: https://hdl.handle.net/11858/00-001M-0000-0029-5C34-A Version Permalink: https://hdl.handle.net/11858/00-001M-0000-002A-3E0F-0

Genre: Journal Article

Files

show Files

Locators

show

Creators

show

hide

Creators:
Timper, Katharina¹, Author
Seelig, Eleonora, Author
Tsakiris, Dimitrios A., Author
Donath, Marc Y., Author

Affiliations:
1Neuronal Control of Metabolism, Department Jens Brüning, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149644

Content

show

Details

show

hide

Language(s): eng - English

Dates: Date issued: 2015

Publication Status: Issued

Pages: -

Publishing info: -

Table of Contents: -

Rev. Type: Peer

Identifiers: DOI: 10.1016/j.jdiacomp.2015.05.019

Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show

hide

Title: Journal of Diabetes and Its Complications

Source Genre: Journal

Creator(s):

Affiliations:

Publ. Info: -

Pages: - Volume / Issue: 29 (7) Sequence Number: - Start / End Page: 955 - 960 Identifier: ISSN: 1056-8727